Patents by Inventor Ezra John Still

Ezra John Still has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8466280
    Abstract: The present invention relates to a novel cocrystal compound of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide (rivaroxaban) and malonic acid, to processes for its preparation, to medicaments comprising this compound and to their use for controlling diseases.
    Type: Grant
    Filed: June 3, 2009
    Date of Patent: June 18, 2013
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Alfons Grunenberg, Karsten Fähnrich, Olaf Queckenberg, Christiane Reute, Birgit Keil, Karen Sue Gushurst, Ezra John Still
  • Patent number: 8183369
    Abstract: 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one as crystalline Form L, methods of obtaining form L, pharmaceutical compositions comprising Form L and methods of using Form L and compositions comprising Form L.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: May 22, 2012
    Assignee: Kudos Pharmaceuticals Limited
    Inventors: Kathryn Anne Quigley, Ezra John Still, Leonard Jesse Chyall
  • Publication number: 20110152266
    Abstract: The present invention relates to a novel cocrystal compound of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide (rivaroxaban) and malonic acid, to processes for its preparation, to medicaments comprising this compound and to their use for controlling diseases.
    Type: Application
    Filed: June 3, 2009
    Publication date: June 23, 2011
    Applicant: Bayer Schering Pharma AG
    Inventors: Alfons Grunenberg, Karsten Fähnrich, Olaf Queckenberg, Christiane Reute, Birgit Keil, Karen Sue Gushurst, Ezra John Still
  • Publication number: 20100286157
    Abstract: 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one as crystalline Form L, methods of obtaining form L, pharmaceutical compositions comprising Form L and methods of using Form L and compositions comprising Form L.
    Type: Application
    Filed: October 17, 2008
    Publication date: November 11, 2010
    Applicant: KUDOS PHARMACEUTICALS LIMITED
    Inventors: Kathryn Anne Quigley, Ezra John Still, Leonard Jesse Chyall